home / stock / aptx / aptx news


APTX News and Press, Aptinyx Inc. From 04/29/21

Stock Information

Company Name: Aptinyx Inc.
Stock Symbol: APTX
Market: OTC
Website: aptinyx.com

Menu

APTX APTX Quote APTX Short APTX News APTX Articles APTX Message Board
Get APTX Alerts

News, Short Squeeze, Breakout and More Instantly...

APTX - Aptinyx shares fell 3% despite positive NYX-783 data in PTSD

Aptinyx (APTX) presents additional data from its exploratory Phase 2 study of NYX-783 in patients with post-traumatic stress disorder ((PTSD)). The study, enrolling 153 patients, consisted of two four-week treatment stages comparing once-daily oral dosing of NYX-783—10mg or 50mg—...

APTX - Aptinyx Presents Additional Positive Data from Phase 2 Exploratory Study of NYX-783 in PTSD at Society of Biological Psychiatry Annual Meeting

Aptinyx Inc. (NASDAQ: APTX), a clinical-stage biopharmaceutical company developing transformative therapies for the treatment of brain and nervous system disorders, today presented additional data from its exploratory Phase 2 study of NYX-783 in patients with post-traumatic stress disor...

APTX - Aptinyx to Participate in Upcoming Conferences

Aptinyx Inc. (Nasdaq: APTX), a clinical-stage biopharmaceutical company developing transformative therapies for the treatment of brain and nervous system disorders, today announced that the Company will be participating in two upcoming conferences: 4 th Annual Neuroscience Inn...

APTX - Best Penny Stocks To Buy Now? 5 For Your Watch List Next Week

Are These On Your List Of Penny Stocks To Buy Right Now? Everyone knows penny stocks can be risky. But with that higher risk comes the potential for higher rewards. Sure penny stocks under $0.50 that jump a quarter or more bring some big wins and great excitement to traders. How about t...

APTX - 3 Hot Penny Stocks To Watch With Important Biotech Events In April 2021

Hot Biotech Penny Stocks To Watch This Month Putting a list of penny stocks together? You might want to check for important dates. The biotech sector is well-known for giving the market plenty of lead time before releasing key information. Furthermore, the beauty of organizations like t...

APTX - Aptinyx shares gain after resuming mid-stage study of NYX-458 in cognitive impairment

Aptinyx (APTX) has recommenced patient screening in a Phase 2 study of NYX-458 in patients with mild cognitive impairment and dementia associated with Parkinson’s disease and dementia with Lewy bodies, following temporary suspension due to escalation of the COVID-19.The compa...

APTX - Aptinyx Recommences Phase 2 Study of NYX-458 in Patients with Cognitive Impairment Associated with Parkinson's Disease Dementia and Dementia with Lewy Bodies

Patient screening has resumed following temporary suspension due to escalation of the COVID-19 pandemic Data readout from the Phase 2 cognitive impairment study expected in 2H 2022 Three Phase 2 data readouts expected over the next 12 to 18 months across the company&#x...

APTX - UEPS, XGN, IKNA and NVAX among after-hours movers

Gainers: [[UEPS]] +4.61%. [[XGN]] +4.5%. [[DISCA]] +4.1%. [[CARG]] +3.3%. [[APTX]] +3.0%.Losers: [[EWTX]] -6.7%. [[NVAX]] -6.6%. [[AACG]] -6.5%. [[IKNA]] -5.9%. [[LSXMK]] -4.5%. For further details see: UEPS, XGN, IKNA and NVAX among after-hours movers

APTX - Aptinyx Inc. 2020 Q4 - Results - Earnings Call Presentation

The following slide deck was published by Aptinyx Inc. in conjunction with their 2020 Q4 earnings call. For further details see: Aptinyx Inc. 2020 Q4 - Results - Earnings Call Presentation

APTX - Aptinyx Inc. (APTX) Q4 2020 Earnings Call Transcript

Image source: The Motley Fool. Aptinyx Inc. (NASDAQ: APTX) Q4 2020 Earnings Call Mar 24, 2021 , 5:00 p.m. ET Operator Continue reading For further details see: Aptinyx Inc. (APTX) Q4 2020 Earnings Call Transcript

Previous 10 Next 10